mafosfamide has been researched along with busulfan in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alessandrino, EP; Bjorkstrand, B; Burnett, A; Carella, A; Gorin, NC; Herve, P; Korbling, M; Labopin, M; Meloni, G; Rizzoli, V | 1 |
| Aglietta, M; Alessandrino, EP; Angrilli, F; Carella, AM; Coleselli, P; Locatelli, F; Madon, E; Mangoni, L; Porcellini, A; Rizzoli, U | 1 |
| Beaujean, F; Benhamou, E; Hartmann, O; Lemerle, J; Rubie, H; Valteau-Couanet, D; Vassal, G | 1 |
| Dreger, P; Fruehauf, S; Ho, AD; Jens Zeller, W; Luft, T; Radujkovic, A; Topaly, J | 1 |
1 review(s) available for mafosfamide and busulfan
| Article | Year |
|---|---|
Autologous bone marrow transplantation for acute myeloblastic leukemia in Europe: further evidence of the role of marrow purging by mafosfamide. European Co-operative Group for Bone Marrow Transplantation (EBMT).
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bone Marrow Purging; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Female; Follow-Up Studies; Humans; Infant; Leukemia, Myeloid, Acute; Male; Meta-Analysis as Topic; Middle Aged; Multivariate Analysis; Prognosis; Risk Factors; Time Factors; Whole-Body Irradiation | 1991 |
1 trial(s) available for mafosfamide and busulfan
| Article | Year |
|---|---|
Drug-mediated marrow purging: mafosfamide in adult acute leukemia in remission. The experience of the Italian study group.
Topics: Adolescent; Adult; Bone Marrow; Bone Marrow Transplantation; Busulfan; Child; Cyclophosphamide; Drug Evaluation; Humans; Infant; Italy; Leukemia, Myeloid, Acute; Middle Aged; Multicenter Studies as Topic; Neoplastic Stem Cells; Postoperative Care; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Preoperative Care; Whole-Body Irradiation | 1989 |
2 other study(ies) available for mafosfamide and busulfan
| Article | Year |
|---|---|
Stage IV neuroblastoma in patients over 1 year of age at diagnosis: consolidation of poor responders with combined busulfan, cyclophosphamide and melphalan followed by in vitro mafosfamide-purged autologous bone marrow transplantation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Busulfan; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Female; Follow-Up Studies; Humans; Infant; Male; Melphalan; Neoplasm Metastasis; Neuroblastoma; Remission Induction; Treatment Outcome | 1997 |
In vitro testing of drug combinations employing nilotinib and alkylating agents with regard to pretransplant conditioning treatment of advanced-phase chronic myeloid leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Benzamides; Busulfan; Cell Proliferation; Cyclophosphamide; Drug Interactions; Drug Resistance, Neoplasm; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; In Vitro Techniques; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Piperazines; Pyrimidines; Transplantation Conditioning; Tumor Cells, Cultured | 2014 |